JP2024174962A5 - - Google Patents
Info
- Publication number
- JP2024174962A5 JP2024174962A5 JP2024153668A JP2024153668A JP2024174962A5 JP 2024174962 A5 JP2024174962 A5 JP 2024174962A5 JP 2024153668 A JP2024153668 A JP 2024153668A JP 2024153668 A JP2024153668 A JP 2024153668A JP 2024174962 A5 JP2024174962 A5 JP 2024174962A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- pharmaceutical composition
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662397988P | 2016-09-22 | 2016-09-22 | |
| US62/397,988 | 2016-09-22 | ||
| US201762442083P | 2017-01-04 | 2017-01-04 | |
| US62/442,083 | 2017-01-04 | ||
| US201762443819P | 2017-01-09 | 2017-01-09 | |
| US62/443,819 | 2017-01-09 | ||
| US201762445774P | 2017-01-13 | 2017-01-13 | |
| US62/445,774 | 2017-01-13 | ||
| US201762519896P | 2017-06-15 | 2017-06-15 | |
| US62/519,896 | 2017-06-15 | ||
| EP17306081.5 | 2017-08-18 | ||
| EP17306081 | 2017-08-18 | ||
| JP2019537047A JP7164530B2 (ja) | 2016-09-22 | 2017-09-21 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
| PCT/US2017/052772 WO2018057776A1 (en) | 2016-09-22 | 2017-09-21 | Methods for treating severe atopic dermatitis by administering an il-4r inhibitor |
| JP2022128592A JP2022160685A (ja) | 2016-09-22 | 2022-08-12 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022128592A Division JP2022160685A (ja) | 2016-09-22 | 2022-08-12 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024174962A JP2024174962A (ja) | 2024-12-17 |
| JP2024174962A5 true JP2024174962A5 (https=) | 2026-04-10 |
Family
ID=59974890
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537047A Active JP7164530B2 (ja) | 2016-09-22 | 2017-09-21 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
| JP2022128592A Pending JP2022160685A (ja) | 2016-09-22 | 2022-08-12 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
| JP2024153668A Pending JP2024174962A (ja) | 2016-09-22 | 2024-09-06 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537047A Active JP7164530B2 (ja) | 2016-09-22 | 2017-09-21 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
| JP2022128592A Pending JP2022160685A (ja) | 2016-09-22 | 2022-08-12 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220110999A1 (https=) |
| EP (2) | EP3515465B1 (https=) |
| JP (3) | JP7164530B2 (https=) |
| KR (3) | KR20230006049A (https=) |
| CN (2) | CN118203659A (https=) |
| AU (2) | AU2017332732B2 (https=) |
| CA (1) | CA3037499A1 (https=) |
| ES (1) | ES2974376T3 (https=) |
| HU (1) | HUE066662T2 (https=) |
| IL (2) | IL265516B2 (https=) |
| MX (3) | MX2019003235A (https=) |
| PL (1) | PL3515465T3 (https=) |
| RU (1) | RU2759630C2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| PL2892927T3 (pl) | 2012-09-07 | 2018-11-30 | Regeneron Pharmaceuticals, Inc. | Sposoby leczenia atopowego zapalenia skóry przez podawanie antagonisty IL-4R |
| TWI755763B (zh) | 2013-06-04 | 2022-02-21 | 美商再生元醫藥公司 | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 |
| TWI634900B (zh) | 2013-07-11 | 2018-09-11 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| KR102695088B1 (ko) | 2014-02-28 | 2024-08-16 | 리제너론 파아마슈티컬스, 인크. | Ｉｌ-4ｒ 길항제의 투여에 의한 피부 감염의 치료 방법 |
| ES2994774T3 (en) | 2016-09-01 | 2025-01-31 | Regeneron Pharma | Methods for preventing or treating allergy by administering an il-4r antagonist |
| CN110746507B (zh) * | 2018-12-25 | 2020-06-26 | 江苏荃信生物医药有限公司 | 抗人白介素4受体α单克隆抗体及其应用 |
| CN113597328B (zh) | 2019-03-21 | 2025-10-31 | 瑞泽恩制药公司 | 用于治疗过敏症的il-4/il-13途径抑制剂和浆细胞消融的组合 |
| CN114173816A (zh) | 2019-08-05 | 2022-03-11 | 瑞泽恩制药公司 | 通过施用il-4r拮抗剂治疗特应性皮炎的方法 |
| JP7836754B2 (ja) | 2019-08-05 | 2026-03-27 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Ｉｌ－４ｒアンタゴニストを投与することによりアレルギーを治療しアレルゲン特異的免疫療法を増強するための方法 |
| JP2024504614A (ja) * | 2021-01-14 | 2024-02-01 | トランスレイト バイオ， インコーポレイテッド | ｍＲＮＡがコードする抗体を送達する方法および組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2990420B1 (en) | 2000-05-26 | 2016-12-21 | Immunex Corporation | Use of interleukin-4 receptor antibodies and compositions thereof |
| DE60127175T2 (de) * | 2000-12-21 | 2007-11-08 | Nektar Therapeutics, San Carlos | Lagerstabile pulverzusammensetzungen mit interleukin-4 rezeptor |
| MXPA06004853A (es) | 2003-11-07 | 2006-07-06 | Immunex Corp | Anticuerpos que se aglutinan al receptor 4 de interleucina. |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| CN101522716B (zh) | 2006-10-02 | 2013-03-20 | 瑞泽恩制药公司 | 抗人il-4受体的高亲和力人抗体 |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| BR112013008366B1 (pt) | 2010-10-06 | 2022-02-08 | Regeneron Pharmaceuticals, Inc | Formulações farmacêuticas líquidas estáveis contendo anticorpos anti-receptor de interleucina-4 humana alfa, e recipiente contendo as referidas formulações |
| PL2892927T3 (pl) | 2012-09-07 | 2018-11-30 | Regeneron Pharmaceuticals, Inc. | Sposoby leczenia atopowego zapalenia skóry przez podawanie antagonisty IL-4R |
| TWI634900B (zh) * | 2013-07-11 | 2018-09-11 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| IL315136A (en) | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| WO2018057776A1 (en) | 2016-09-22 | 2018-03-29 | Regeneron Pharmaceuticals, Inc. | Methods for treating severe atopic dermatitis by administering an il-4r inhibitor |
-
2017
- 2017-09-21 RU RU2019111921A patent/RU2759630C2/ru active
- 2017-09-21 EP EP17777145.8A patent/EP3515465B1/en active Active
- 2017-09-21 CA CA3037499A patent/CA3037499A1/en active Pending
- 2017-09-21 ES ES17777145T patent/ES2974376T3/es active Active
- 2017-09-21 CN CN202410243081.1A patent/CN118203659A/zh active Pending
- 2017-09-21 MX MX2019003235A patent/MX2019003235A/es unknown
- 2017-09-21 CN CN201780071612.1A patent/CN109963577B/zh active Active
- 2017-09-21 KR KR1020227045686A patent/KR20230006049A/ko not_active Ceased
- 2017-09-21 KR KR1020247032347A patent/KR20240146104A/ko active Pending
- 2017-09-21 PL PL17777145.8T patent/PL3515465T3/pl unknown
- 2017-09-21 IL IL265516A patent/IL265516B2/en unknown
- 2017-09-21 IL IL310371A patent/IL310371A/en unknown
- 2017-09-21 AU AU2017332732A patent/AU2017332732B2/en active Active
- 2017-09-21 KR KR1020197011455A patent/KR20190053250A/ko not_active Ceased
- 2017-09-21 HU HUE17777145A patent/HUE066662T2/hu unknown
- 2017-09-21 EP EP23216251.1A patent/EP4345110A3/en active Pending
- 2017-09-21 JP JP2019537047A patent/JP7164530B2/ja active Active
-
2019
- 2019-03-21 MX MX2024011262A patent/MX2024011262A/es unknown
- 2019-03-21 MX MX2023014187A patent/MX2023014187A/es unknown
-
2021
- 2021-09-22 US US17/482,273 patent/US20220110999A1/en active Pending
-
2022
- 2022-08-12 JP JP2022128592A patent/JP2022160685A/ja active Pending
-
2024
- 2024-06-11 AU AU2024203951A patent/AU2024203951A1/en active Pending
- 2024-09-06 JP JP2024153668A patent/JP2024174962A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024174962A5 (https=) | ||
| JP2025172841A5 (https=) | ||
| JP2021523188A5 (https=) | ||
| BR112021008778A2 (pt) | Métodos de tratamento da oftalmopatia de graves usando anticorpos anti-fcrn | |
| EP2442832B1 (en) | Compositions and methods for treatment of multiple sclerosis | |
| KR102622280B1 (ko) | 항-hsv 항체의 국소 적용 | |
| CN104755495A (zh) | 通过施用il-4r拮抗剂治疗或预防哮喘的方法 | |
| JP2022160685A5 (https=) | ||
| JP2024001125A (ja) | Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| JP2019529560A5 (https=) | ||
| IL310133A (en) | IL-13 antibodies for the treatment of atopic dermatitis | |
| JPWO2019222055A5 (https=) | ||
| TW202043282A (zh) | 結節性癢疹患者皮膚病灶及搔癢症之治療 | |
| JP2021532176A5 (https=) | ||
| AU2016294332A1 (en) | Treatment of pruritus | |
| JPWO2021195530A5 (https=) | ||
| JP2021147383A (ja) | アトピー性皮膚炎及び関連障害を処置するための方法 | |
| JPWO2023019171A5 (https=) | ||
| IL297217A (en) | pan-elr antibodies and chemokine cxc for the treatment of respiratory diseases | |
| TW202114734A (zh) | Il-17拮抗劑治療自身免疫疾病的方法 | |
| WO2021191220A1 (en) | Methods for treating atopic dermatitis and related disorders | |
| CN108014337B (zh) | 一种用于治疗眼自身免疫性葡萄膜炎的药物组合物 | |
| JPWO2020012244A5 (https=) | ||
| JPWO2023028468A5 (https=) | ||
| CN112512579A (zh) | Tlr激动剂与免疫检查点抑制剂联合在制备治疗肿瘤的药物中的用途 |